Gut bacteria may forecast surgery risks in pancreatic cancer patients

NCT ID NCT06381882

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is collecting saliva, stool, blood, bile, and tumor samples from 200 people undergoing surgery for pancreatic or related cancers. Researchers want to see if the types of bacteria in these samples can help predict who will have complications after surgery and how the cancer may behave long-term. The goal is to better understand the role of the microbiome in recovery and disease progression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a way to predict which patients are at higher risk for complications after pancreatic surgery, helping doctors tailor care.
What could go wrong
This is an observational study, not a treatment trial. It may find no clear link between the microbiome and outcomes, or the results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MICROBIAL COLONIZATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • St. Antonius Hospital

    Nieuwegein, 3435CM, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.